US EditionPublished • loading... • Updated
What to know about how GLP-1 medications might fight addiction
A large study found GLP-1 drugs, used for diabetes and obesity, are linked to lower risks of multiple substance use disorders and their negative effects.
- A large new study found GLP-1 drugs may help prevent multiple substance use disorders, as reported by the Associated Press, David J. Phillip.
- Those GLP-1 drugs previously reshaped treatment for diabetes and obesity, with Ozempic, an injectable GLP-1 medication, as an example, according to the Associated Press.
- A large analysis of health data by researchers identified associations between GLP-1 use and substance-related outcomes in a large, new study.
- The study reported lower rates of 'tragic' outcomes among people with substance use disorders using GLP-1 drugs, with coverage highlighting potential public-health relevance.
- The finding links a diabetes and obesity treatment class to addiction-related outcomes, reported by the Associated Press, highlighting wider attention to the cross-condition association.
Insights by Ground AI
21 Articles
21 Articles
GLP-1's may curb more than just appetites: Dr. Peter Lin
GLP-1 medications are in the spotlight yet again. New research shows drugs like Ozempic and Wegovy can curb addiction to a variety of substances including drugs and alcohol. Dr. Peter Lin explains how they temper temptation.
·Canada
Read Full Article
The Billings Gazette+19 Reposted by 19 other sources
What to know about how GLP-1 medications might fight addiction
The blockbuster GLP-1 drugs that reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce their tragic outcomes, a large new study found.
·Billings, United States
Read Full ArticleCoverage Details
Total News Sources21
Leaning Left1Leaning Right0Center20Last UpdatedBias Distribution95% Center
Bias Distribution
- 95% of the sources are Center
95% Center
C 95%
Factuality
To view factuality data please Upgrade to Premium
